BamSEC and AlphaSense Join Forces
Learn More

Neurogene Inc.

NASDAQ: NGNE    
Share price (1/6/25): $23.12    
Market cap (1/6/25): $343 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.3
from 8-K 20 pages Amended and Restated Bylaws of Neurogene Inc
12/34/56
EX-3.2
from 8-K 5 pages Amended and Restated Certificate of Incorporation of Neurogene Inc. (A Delaware Corporation) I
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Neoleukin Therapeutics, Inc. “I
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Neoleukin Therapeutics, Inc
12/34/56
EX-3.1
from 8-K/A 28 pages Neoleukin Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws as Amended and Restated on November 30, 2022 Neoleukin Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 27 pages Neoleukin Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws as Amended and Restated on November 30, 2022 Neoleukin Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 18 pages Amended and Restated Bylaws of Neoleukin Therapeutics, Inc. (A Delaware Corporation) Amended and Restated Bylaws of Neoleukin Therapeutics, Inc
12/34/56
EX-3.5
from 10-Q 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Neoleukin Therapeutics, Inc
12/34/56
EX-3.4
from 10-Q 3 pages State of Delaware Secretary of State Division of Corporations Delivered 05:11 Pm 08/09/2019 Filed 05:11 Pm 08/09/2019 Sr 20196447084 - File Number 4359857 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 11 pages Aquinox Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law August 8, 2019 Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc
12/34/56
EX-3.6
from S-1/A 25 pages Amended and Restated Bylaws of Aquinox Pharmaceuticals Inc. (A Delaware Corporation) Amended and Restated Bylaws of Aquinox Pharmaceuticals Inc
12/34/56
EX-3.5
from S-1/A 6 pages Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1/A 3 pages Certificate of Amendment of Sixth Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1 15 pages Aquinox Pharmaceuticals (USA) Inc. Second Amended and Restated Bylaws June 11, 2010
12/34/56
EX-3.2
from S-1 3 pages Certificate of Amendment of Sixth Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals (USA) Inc
12/34/56
EX-3.1
from S-1 33 pages Sixth Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals (USA) Inc. Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware
12/34/56
EX-3
from DRS/A 15 pages Aquinox Pharmaceuticals (USA) Inc. Second Amended and Restated Bylaws June 11, 2010
12/34/56
EX-3.2
from DRS 15 pages Aquinox Pharmaceuticals (USA) Inc. Second Amended and Restated Bylaws June 11, 2010
12/34/56
EX-3.1
from DRS 33 pages Sixth Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals (USA) Inc. Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware
12/34/56